Loading…

The effects of the growth factor-antagonist, trapidil, on remyelination in the CNS

In this study we describe the effects of trapidil, a putative platelet-derived growth factor-antagonist, on spontaneously occurring remyelination in rat spinal cord. Demyelination was created in the dorsal funiculus of 6- and 11-week-old female rats by the direct injection of 1.0 microliter of 1% ly...

Full description

Saved in:
Bibliographic Details
Published in:Neuropathology and applied neurobiology 1997-02, Vol.23 (1), p.50-57
Main Authors: MCKAY, J. S, BLAKEMORE, W. F, FRANKLIN, R. J. M
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c306t-83facb2a66f7e48aa39d13e94e257ee3733b7376c2e49bab599279169ec7ff653
cites
container_end_page 57
container_issue 1
container_start_page 50
container_title Neuropathology and applied neurobiology
container_volume 23
creator MCKAY, J. S
BLAKEMORE, W. F
FRANKLIN, R. J. M
description In this study we describe the effects of trapidil, a putative platelet-derived growth factor-antagonist, on spontaneously occurring remyelination in rat spinal cord. Demyelination was created in the dorsal funiculus of 6- and 11-week-old female rats by the direct injection of 1.0 microliter of 1% lysolecithin. The animals received daily intra-peritoneal injections of either trapidil or saline for 21 days, commencing on the day of lesion induction. The 11-week-old rats receiving trapidil (60 mg/kg) showed a significant decrease in the extent of oligodendrocyte remyelination. Moreover, those axons that were remyelinated by oligodendrocytes tended to have thinner myelin sheaths than axons remyelinated by oligodendrocytes in the control group. In the 6-week-old group, the dose of trapidil which inhibited oligodendrocyte remyelination in the 11-week-old animals had a minimal effect on the extent of oligodendrocyte remyelination and no effect on the quality of myelin sheath formation. A higher dose of trapidil (80 mg/kg) was required before significant impairment of oligodendrocyte remyelination was achieved in the younger age group, implying an age-dependent effect of growth factor-inhibition of CNS remyelination. These results indicate an important role for growth factors, and in particular PDGF, in the orchestration of oligodendrocyte remyelination in the rodent CNS.
doi_str_mv 10.1046/j.1365-2990.1997.7098070.x
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_78865762</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>78865762</sourcerecordid><originalsourceid>FETCH-LOGICAL-c306t-83facb2a66f7e48aa39d13e94e257ee3733b7376c2e49bab599279169ec7ff653</originalsourceid><addsrcrecordid>eNqFkFtLAzEQhYMoWqs_QVhEfOrW7GZz802KNxAFL88hm05qyna3Jinaf29ql776NMycc2aSD6HzAo8LXLGr-bggjOallGkgJR9zLAXmePyzhwY7aR8NMME0L0TFjtBxCHOMMeVMHqJDiVnBJB6g1_dPyMBaMDFknc1iame--46fmdUmdj7XbdSzrnUhjrLo9dJNXTPKujbzsFhD41odXepc-5edPL-doAOrmwCnfR2ij7vb98lD_vRy_zi5ecoNwSzmgqQDdakZsxwqoTWR04KArKCkHIBwQmpOODMlVLLWNZWy5DK9Ggy3llEyRJfbvUvffa0gRLVwwUDT6Ba6VVBcCJa-W_5rLNIyQoVMxuut0fguBA9WLb1baL9WBVYb8mquNnjVBq_akFc9efWTwmf9lVW9gOku2qNO-kWv62B0Y71ujQs7W0mlECUlv6tujDk</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>16533589</pqid></control><display><type>article</type><title>The effects of the growth factor-antagonist, trapidil, on remyelination in the CNS</title><source>Wiley</source><creator>MCKAY, J. S ; BLAKEMORE, W. F ; FRANKLIN, R. J. M</creator><creatorcontrib>MCKAY, J. S ; BLAKEMORE, W. F ; FRANKLIN, R. J. M</creatorcontrib><description>In this study we describe the effects of trapidil, a putative platelet-derived growth factor-antagonist, on spontaneously occurring remyelination in rat spinal cord. Demyelination was created in the dorsal funiculus of 6- and 11-week-old female rats by the direct injection of 1.0 microliter of 1% lysolecithin. The animals received daily intra-peritoneal injections of either trapidil or saline for 21 days, commencing on the day of lesion induction. The 11-week-old rats receiving trapidil (60 mg/kg) showed a significant decrease in the extent of oligodendrocyte remyelination. Moreover, those axons that were remyelinated by oligodendrocytes tended to have thinner myelin sheaths than axons remyelinated by oligodendrocytes in the control group. In the 6-week-old group, the dose of trapidil which inhibited oligodendrocyte remyelination in the 11-week-old animals had a minimal effect on the extent of oligodendrocyte remyelination and no effect on the quality of myelin sheath formation. A higher dose of trapidil (80 mg/kg) was required before significant impairment of oligodendrocyte remyelination was achieved in the younger age group, implying an age-dependent effect of growth factor-inhibition of CNS remyelination. These results indicate an important role for growth factors, and in particular PDGF, in the orchestration of oligodendrocyte remyelination in the rodent CNS.</description><identifier>ISSN: 0305-1846</identifier><identifier>EISSN: 1365-2990</identifier><identifier>DOI: 10.1046/j.1365-2990.1997.7098070.x</identifier><identifier>PMID: 9061690</identifier><identifier>CODEN: NANEDL</identifier><language>eng</language><publisher>Oxford: Blackwell Science</publisher><subject>Animals ; Antianginal agents. Coronary vasodilator agents ; Biological and medical sciences ; Cardiovascular system ; Central Nervous System - drug effects ; Female ; Medical sciences ; Myelin Proteins - drug effects ; Pharmacology. Drug treatments ; Rats ; Spinal Cord - drug effects ; Trapidil - pharmacology</subject><ispartof>Neuropathology and applied neurobiology, 1997-02, Vol.23 (1), p.50-57</ispartof><rights>1997 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c306t-83facb2a66f7e48aa39d13e94e257ee3733b7376c2e49bab599279169ec7ff653</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=2598825$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9061690$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>MCKAY, J. S</creatorcontrib><creatorcontrib>BLAKEMORE, W. F</creatorcontrib><creatorcontrib>FRANKLIN, R. J. M</creatorcontrib><title>The effects of the growth factor-antagonist, trapidil, on remyelination in the CNS</title><title>Neuropathology and applied neurobiology</title><addtitle>Neuropathol Appl Neurobiol</addtitle><description>In this study we describe the effects of trapidil, a putative platelet-derived growth factor-antagonist, on spontaneously occurring remyelination in rat spinal cord. Demyelination was created in the dorsal funiculus of 6- and 11-week-old female rats by the direct injection of 1.0 microliter of 1% lysolecithin. The animals received daily intra-peritoneal injections of either trapidil or saline for 21 days, commencing on the day of lesion induction. The 11-week-old rats receiving trapidil (60 mg/kg) showed a significant decrease in the extent of oligodendrocyte remyelination. Moreover, those axons that were remyelinated by oligodendrocytes tended to have thinner myelin sheaths than axons remyelinated by oligodendrocytes in the control group. In the 6-week-old group, the dose of trapidil which inhibited oligodendrocyte remyelination in the 11-week-old animals had a minimal effect on the extent of oligodendrocyte remyelination and no effect on the quality of myelin sheath formation. A higher dose of trapidil (80 mg/kg) was required before significant impairment of oligodendrocyte remyelination was achieved in the younger age group, implying an age-dependent effect of growth factor-inhibition of CNS remyelination. These results indicate an important role for growth factors, and in particular PDGF, in the orchestration of oligodendrocyte remyelination in the rodent CNS.</description><subject>Animals</subject><subject>Antianginal agents. Coronary vasodilator agents</subject><subject>Biological and medical sciences</subject><subject>Cardiovascular system</subject><subject>Central Nervous System - drug effects</subject><subject>Female</subject><subject>Medical sciences</subject><subject>Myelin Proteins - drug effects</subject><subject>Pharmacology. Drug treatments</subject><subject>Rats</subject><subject>Spinal Cord - drug effects</subject><subject>Trapidil - pharmacology</subject><issn>0305-1846</issn><issn>1365-2990</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1997</creationdate><recordtype>article</recordtype><recordid>eNqFkFtLAzEQhYMoWqs_QVhEfOrW7GZz802KNxAFL88hm05qyna3Jinaf29ql776NMycc2aSD6HzAo8LXLGr-bggjOallGkgJR9zLAXmePyzhwY7aR8NMME0L0TFjtBxCHOMMeVMHqJDiVnBJB6g1_dPyMBaMDFknc1iame--46fmdUmdj7XbdSzrnUhjrLo9dJNXTPKujbzsFhD41odXepc-5edPL-doAOrmwCnfR2ij7vb98lD_vRy_zi5ecoNwSzmgqQDdakZsxwqoTWR04KArKCkHIBwQmpOODMlVLLWNZWy5DK9Ggy3llEyRJfbvUvffa0gRLVwwUDT6Ba6VVBcCJa-W_5rLNIyQoVMxuut0fguBA9WLb1baL9WBVYb8mquNnjVBq_akFc9efWTwmf9lVW9gOku2qNO-kWv62B0Y71ujQs7W0mlECUlv6tujDk</recordid><startdate>19970201</startdate><enddate>19970201</enddate><creator>MCKAY, J. S</creator><creator>BLAKEMORE, W. F</creator><creator>FRANKLIN, R. J. M</creator><general>Blackwell Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7X8</scope></search><sort><creationdate>19970201</creationdate><title>The effects of the growth factor-antagonist, trapidil, on remyelination in the CNS</title><author>MCKAY, J. S ; BLAKEMORE, W. F ; FRANKLIN, R. J. M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c306t-83facb2a66f7e48aa39d13e94e257ee3733b7376c2e49bab599279169ec7ff653</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1997</creationdate><topic>Animals</topic><topic>Antianginal agents. Coronary vasodilator agents</topic><topic>Biological and medical sciences</topic><topic>Cardiovascular system</topic><topic>Central Nervous System - drug effects</topic><topic>Female</topic><topic>Medical sciences</topic><topic>Myelin Proteins - drug effects</topic><topic>Pharmacology. Drug treatments</topic><topic>Rats</topic><topic>Spinal Cord - drug effects</topic><topic>Trapidil - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>MCKAY, J. S</creatorcontrib><creatorcontrib>BLAKEMORE, W. F</creatorcontrib><creatorcontrib>FRANKLIN, R. J. M</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Neuropathology and applied neurobiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>MCKAY, J. S</au><au>BLAKEMORE, W. F</au><au>FRANKLIN, R. J. M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The effects of the growth factor-antagonist, trapidil, on remyelination in the CNS</atitle><jtitle>Neuropathology and applied neurobiology</jtitle><addtitle>Neuropathol Appl Neurobiol</addtitle><date>1997-02-01</date><risdate>1997</risdate><volume>23</volume><issue>1</issue><spage>50</spage><epage>57</epage><pages>50-57</pages><issn>0305-1846</issn><eissn>1365-2990</eissn><coden>NANEDL</coden><abstract>In this study we describe the effects of trapidil, a putative platelet-derived growth factor-antagonist, on spontaneously occurring remyelination in rat spinal cord. Demyelination was created in the dorsal funiculus of 6- and 11-week-old female rats by the direct injection of 1.0 microliter of 1% lysolecithin. The animals received daily intra-peritoneal injections of either trapidil or saline for 21 days, commencing on the day of lesion induction. The 11-week-old rats receiving trapidil (60 mg/kg) showed a significant decrease in the extent of oligodendrocyte remyelination. Moreover, those axons that were remyelinated by oligodendrocytes tended to have thinner myelin sheaths than axons remyelinated by oligodendrocytes in the control group. In the 6-week-old group, the dose of trapidil which inhibited oligodendrocyte remyelination in the 11-week-old animals had a minimal effect on the extent of oligodendrocyte remyelination and no effect on the quality of myelin sheath formation. A higher dose of trapidil (80 mg/kg) was required before significant impairment of oligodendrocyte remyelination was achieved in the younger age group, implying an age-dependent effect of growth factor-inhibition of CNS remyelination. These results indicate an important role for growth factors, and in particular PDGF, in the orchestration of oligodendrocyte remyelination in the rodent CNS.</abstract><cop>Oxford</cop><pub>Blackwell Science</pub><pmid>9061690</pmid><doi>10.1046/j.1365-2990.1997.7098070.x</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0305-1846
ispartof Neuropathology and applied neurobiology, 1997-02, Vol.23 (1), p.50-57
issn 0305-1846
1365-2990
language eng
recordid cdi_proquest_miscellaneous_78865762
source Wiley
subjects Animals
Antianginal agents. Coronary vasodilator agents
Biological and medical sciences
Cardiovascular system
Central Nervous System - drug effects
Female
Medical sciences
Myelin Proteins - drug effects
Pharmacology. Drug treatments
Rats
Spinal Cord - drug effects
Trapidil - pharmacology
title The effects of the growth factor-antagonist, trapidil, on remyelination in the CNS
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T15%3A36%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20effects%20of%20the%20growth%20factor-antagonist,%20trapidil,%20on%20remyelination%20in%20the%20CNS&rft.jtitle=Neuropathology%20and%20applied%20neurobiology&rft.au=MCKAY,%20J.%20S&rft.date=1997-02-01&rft.volume=23&rft.issue=1&rft.spage=50&rft.epage=57&rft.pages=50-57&rft.issn=0305-1846&rft.eissn=1365-2990&rft.coden=NANEDL&rft_id=info:doi/10.1046/j.1365-2990.1997.7098070.x&rft_dat=%3Cproquest_cross%3E78865762%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c306t-83facb2a66f7e48aa39d13e94e257ee3733b7376c2e49bab599279169ec7ff653%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=16533589&rft_id=info:pmid/9061690&rfr_iscdi=true